MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
2020 · Gastroenterology · 3,178 citations
https://doi.org/10.1053/j.gastro.2019.11.312
R
Rohit Loomba
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.2K
Papers
101.2K
Citations
154
h-index
606
i10-index
Rohit Loomba is an academic researcher from University of California San Diego. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver Disease and Transplantation & Liver Diseases and Immunity. The author has an h-index of 154, co-authored 1054 publications.
ORCID: 0000-0002-4845-9991Papers by this author
worksA multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Hepatology · 2,642 citations
https://doi.org/10.1097/hep.0000000000000520
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
2023 · Journal of Hepatology · 2,472 citations
https://doi.org/10.1016/j.jhep.2023.06.003
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 · Hepatology · 1,958 citations
https://doi.org/10.1097/hep.0000000000000323
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
2018 · Journal of Hepatology · 1,933 citations
https://doi.org/10.1016/j.jhep.2018.05.036
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 · Hepatology · 1,795 citations
https://doi.org/10.1002/hep.29085
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat